Abstract-A subminiature implantable potentiostat and telemetry electronics package was developed to provide remote monitoring of implantable amperometric glucose sensors. Included are a new potentiostat for sensor biasing, a transimpedance amplifier to produce the sensor-current proportional voltage, and an optically coupled interface to the commercially available telemetry unit which transmits glucose concentration data to a corresponding receiver and computer. Potentiostat components were individually tested in vitro for accuracy and stability, and as a system utilizing telemetry for end-to-end remote data monitoring. In vitro calibrations of a glucose sensor obtained with our subminiature potentiostat/telemetry unit and a traditional potentiostat correlated extremely well (R 2 = 0.9994). Instrumentation developed in this paper will allow other researchers to easily develop implantable units for their own applications.
D
IABETIC patients typically monitor glycemia by fingerpricking to obtain capillary blood samples. These tests (up to six times a day) are painful and time-consuming; thus patients tend to resist performing an adequate number of daily glucose measurements. Low compliance and intermittent sampling lead to the extensive pathology seen in diabetic patients [1] . Therefore, we and several other researchers are developing glucose sensors to replace finger-pricking. Our present configuration is a flexible miniaturized sensor (0.5 mm diameter) designed for subcutaneous implantation. We utilize a two-electrode design, having a glucose workingindicating platinum (Pt) electrode and a Ag/AgCl referencecounter electrode, with a three-layer membrane configuration of Nafion, glucose oxidase and poly( -phenylenediamine) (PPD). In vitro evaluations have shown a linear response up to 20 mM glucose, a high sensitivity, a low background current, a short response time (about 30 s), and a high selectivity for glucose [2] . For in vivo evaluation, our sensor was implanted percutaneously into the backs of dogs, and tested over a Manuscript received May 13, 1999 ; revised September 15, 1999 . This work was supported by the Juvenile Diabetes Foundation International and the Whitaker Foundation.
The authors are with the Center for Biomaterials and Surgical Research Center, University of Connecticut Health Center, Farmington, CT 06030-1615 USA.
Publisher Item Identifier S 0018-9456(99)09596-0.
ten-day period [2] - [4] . These experiments showed that the response of some of our sensors was stable for at least ten days, while others failed. Reliability problems, common to all implantable glucose sensors developed worldwide, are believed to be caused primarily by the tissue reaction to the sensor [5] , [6] .
To evaluate implantable glucose sensors in animals and ultimately in patients, a subminiature potentiostat to bias the sensor with an excitation voltage, and a telemetry unit to transmit sensor information to an external miniaturized receiver, are needed. Several groups working on glucose sensors developed their own implantable potentiostat/telemetry units [7] - [14] , all of which were based on FM transmission of glucose concentration data. This paper presents a new subminiature implantable potentiostat/telemetry unit based on a commercially available telemetry unit from Ambulatory Monitoring Inc. (AMI), Ardsley, NY, that utilizes a newer digital transmission methodology. This AMI implantable unit was initially developed for temperature monitoring, and contains the power supply, operational amplifiers, microprocessor chips, capacitors, resistors and radio-transmitter components. We modified the unit to adapt it for use with an implantable glucose sensor by utilizing an optocoupler and new circuitry for the sensor voltage source. By using the commercially available telemetry device and the circuitry that we have developed, other researchers can easily develop their own implantable units.
II. MATERIALS AND METHODS
Our subminiature glucose monitoring system includes an amperometric glucose sensor, a potentiostat, an optocoupler, and a commercially available telemetry device. Fig. 1 is the circuit schematic for the system. The use of surface-mounttechnology devices necessitated the design and manufacture of a printed-circuit board. The potentiostat's adjustable bias voltage (P1) powers the sensor. The platinum (Pt) workingindicating electrode of the glucose sensor connects to the op amp output at the TP1 location for a bias voltage, and the Ag/AgCl reference-counter electrode at the S2 location. A transimpedance amplifier converts the sensor-generated current to an output voltage. This sensor-current-based voltage component (S2) is added to a biasing-current-offset-voltage component (S3), amplified, and used to drive the optocoupler (S4) in the desired voltage range. As sensor voltage varies due 0018-9456/99$10.00 © 1999 IEEE to the glucose concentration, the optocoupler output resistance changes. This resistance is connected to the telemetry device (sometimes referred to as a "puck" due to its hockey-puck shape), which converts resistance to a digital value within its microprocessor. The implanted telemetry-unit puck transmits the digital resistance value by on-off key (OOK) modulating its radio-transmitter carrier frequency and sending a digital serial data transmission stream to the receiver via its internal antenna. The "OOK" technique conserves battery life, as opposed to using continuous frequency modulation (FM). The receiver demodulates the digitally based serial data and sends it to the computer using the RS232 protocol. Monitoring software provides an on-screen readout and logs the data file to disk.
A. Development of the Potentiostat and Telemetry Unit
To minimize implant size and component number, we used a Maxim MAX951 CMOS 8-pin micromax size (80% of Surface Mount Technology) IC. Power is provided by an AA-size 3.7 VDC lithium-thionyl-chloride battery (2200 mAh capacity). A MAX1044 voltage converter provides 3.7 VDC. C2 (bucket capacitor) and C3 (reservoir capacitor) were 10 F, for a 2 mA current capacity (100 F for 20 mA). A C4 of 100 F reduced quiescent current to 15 A. The MAX951 contains a micropower op-amp, 1.2 volt internal reference and a comparator. P1 (1 M ) adjustment provides a sensor excitation of 0.7 VDC. The MAX951 op-amp has a low bias current of 3 A, high input impedance, and very low quiescent current of 7 A. The glucose sensor produces a current proportional to glucose concentrations in the range of 1 nA to 2000 nA. The Pt sensor electrode is connected to the 0.7 VDC, and the Ag/AgCl electrode to another MAX951 for current-to-voltage conversion. An R1 of 50 k yields 100 mV at 2000 nA. A low-pass filter was created at the op-amp by adding a C1 of 22 F ( 3 dB break frequency at 1/(2 RC)). The output voltage (at TP2) drives the optocoupler. Switches S1, S2, S3 and S4 are used for the battery power, glucose sensor, optocoupler biasing voltage, and the optocoupler, respectively. Turning S2 off (open) and S3 on (closed) is useful to adjust the optocoupler biasing voltage using P2 (100 k ), and for observing voltage, resistance or telemetered computer values. Turning S3 off (open) and S2 on (closed) allows the circuit to function as a normal potentiostat, indicating the sensor output voltages only. S4 loads or unloads the circuit of the optocoupler, although a normal optocoupler does not affect voltage indications at TP2, whether in or out of the circuit.
B. Subminiature PC Board and IC Components
A surface-mount printed-circuit board was designed via a PC-board software design package called Eagle. The software produces Gerber-formatted output data files which were supplied to AP Circuits of Calgary, AB Canada, for PC board manufacturing. Fig. 2 shows the design-layout of the manufactured PC board and pictures of the board with installed components.
C. Optocoupler Interface for Telemetry Puck
We chose a VTL5C2 EG&G Vactec optocoupler [15] , which is essentially an LED in an epoxy module with a light-dependent resistor (LDR) or photoresistor. Our testing verified stable and repeatable output resistance to replace the original thermistor. The puck can transmit resistance values from 0 to 65 535 digital counts (ohms/10), representing 0 to 655 350 . The original puck thermistor was a Thermometrics MC65Y type with a nominal resistance of 100 000 , and at 40 mA and 100 000 at about 0.16 mA [15] . The optocoupler has a negative coefficient behavior where increasing current and voltage results in lower output resistance. There is some hysteresis effect with a resistance set due to prolonged light or dark exposure (i.e. light exposure implies conducting current and lower resistances, dark implies no conduction and higher resistances), and some temperature effect. Neither of these presents a problem since the optocoupler will always have a current flowing in a "light on" condition with relatively stable temperature.
D. Commercially Available Telemetry Puck and Minor Modification
The puck is 26 mm in diameter and 9 mm high. The thermistor was removed to provide a two-wire attachment for the optocoupler resistance. A software modification was made to change the computer readout from calculated temperature to digital telemetered counts representing the glucose levels. The puck can be activated (on and transmitting data) with transmission intervals from 5 s to 10 min, or deactivated (asleep and not transmitting data). When deactivated, it is in standby and still uses battery current since it must receive an activation commands. The puck can operate for 3 months with its internal CR2025 LiMnO2 battery at 5-s transmission intervals, and a year with longer intervals of up to 10 min. Transmissions utilize a frequency of 303.825 MHz.
E. Telemetry Receiver and Computer Readout
The receiver (6.8 cm 11.5 cm 2.54 cm) was provided by AMI. A nine-pin "D" type connector attaches it to a computer serial port, and an antenna receives puck data. The puck is placed on the receiver to be activated, deactivated, or reprogrammed with a new data transmission interval. The software runs on any DOS based computer. The readout includes diagnostic information pertaining to puck data communication, serial number (since system can handle up to 40 pucks simultaneously), digital resistance, and timer seconds left until logging to file (at 1-min intervals).
F. Calibration of Glucose Sensor
Calibration of the systems with the glucose sensor, were done in a stirred 10-ml PBS solution at 37 C. After reaching the proper temperature, the sensor was immersed in the solution, the circuit was activated, and the sensor was turned on. Approximately 10 min was allowed for stabilization between calibration steps. Calibrations were performed at 0, 5.66, 10.71, 15.25, and 19.35 glucose. When a puck is activated, a file is opened for data logging and is saved continuously, so a power outage or computer reboot will not cause a loss of data. The default data transmission interval is 5 s, and logging every minute. These were the parameters we used.
III. RESULTS AND DISCUSSION
Transmitting the in vivo signal created by a glucose sensor to an external receiver using telemetry, has only been done by a few groups generally utilizing similar technology (i.e. FM transmitter and receiver) [7] - [14] . In these systems, the potentiostat created a voltage proportional to the glucose level, which drove the voltage-to-frequency converter, which then modulated the FM transmitter carrier frequency. At the receiver, the signal required demodulation for the data frequency representing the glucose concentration data. Typical problems are the size of the devices and the fact that all of the modulation and demodulation steps are potential error sources.
Since we also wanted the receiver to be worn by an individual, a very small receiver and transmitter were both required. To minimize size and error sources, we converted data to digital form using an implanted microprocessor. The transmitter sends serial data to the receiver, and then to the computer serial port minimizing conversion errors. Calibrations provide direct real-time glucose data determination. Our smaller implant uses less current, since voltage-controlled oscillators are not required for voltage-to-frequency conversion. At the receiver, no frequency-to-voltage conversion or frequency counting is required, thus resulting in less noise, and better data stability and accuracy.
Development was done in stages. Breadboard potentiostat assembly and testing was performed prior to the surface mount subminiaturization process. The optocoupler was characterized individually to determine its suitability, and then tested in the assembly. The puck was tested to verify that it could transmit applied resistances accurately, before it was used in the assembly. Ultimately, full system "end-to-end" calibrations, from glucose sensor through computer digital resistance readout, were done using the subminiature potentiostat to verify integrity and accuracy. Fig. 1 is the schematic for the breadboard and subminiature potentiostat. There were essentially no component changes between the two, except multiturn trimmer resistors (P1 and P2) were replaced with 270 turn SMT equivalents. Also, ON/OFF switches S1 (power), S2 (sensor), and S4 (optocoupler) were eliminated, and S3 (bias) ON/OFF replaced with a solder link. Stability of the 1.2 VDC reference and op-amp was verified by setting the sensor biasing voltage to 0.700 VDC using the P1 potentiometer. Monitoring over a 10-week period showed little variation, with a maximum of 0.705 VDC. Glucose sensor substitute 1% resistors were used, simulating 0 and 3500 nA, to Fig. 3 shows a comparison of a standard potentiostat sensor calibration to the average of three calibrations done with the breadboard potentiostat. Note the excellent and linear fit correlation
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B. Characterization of Optocoupler Device
The operating voltage range needed to stay below a maximum digital resistance count value of 65 535 (655 350 ) was determined. Fig. 4(b) is a dual plot of voltage versus current, and resistance versus current. The resistance versus current data, measured at room temperature, is reflected in 3 superimposed curves, repeating very closely. Resistances between 140 k (100 A) and 10 k (1.1 mA) minimize battery current. The voltage versus current curve shows 100 A at 1.453 VDC, and 1.1 mA at 1.553 VDC. Thus, the sensor voltage contribution had to be from 0 to 100 mV, with a bias voltage of 1.453 V. At 2000 nA maximum sensor design current, the amplifier gain resistor had to be mV/2000 nA 50 k Thus, at 0 mM of glucose there will be 1.453 VDC plus any small sensor background current generated voltage, and at 20 mM glucose (2000 nA), we will see 1.553 VDC. Fig. 4(a) Graph symbols obscured the data and could not be used.
2) Voltages were applied to the optocoupler serving as the puck input, and the resistances observed at the computer. This verified the functional concept, and the absence of loading problems. A plot of seven calibrations (data not shown) showed small S. D. bars below 400 k ( ), 160 k ( ), 40 k ( ), 10 k ( ), showing the repeatability and accuracy ( with a fourth order polynomial curve fit). A correlation of the optocoupler characterization in Fig. 4(a) to the item 2) voltage test above, showed accurate telemetry recorded resistances with a linear and (data not shown). Orientation testing was conducted at 1 m. A substitute sensor resistance value of 1 M provided 700 nA at 0.7 VDC, for an optocoupler resistance of 55 900 to be monitored. Positions over 360 in each of the two axes at 90 offset, were covered in 45 steps with no data dropouts.
These results validate the use of the AMI telemetry puck. Our results also agree with work done by Dr. Daniel Redmond at the Walter Reed Army Institute of Research, who tested the puck in live Rhesus monkeys (personal communication, unpublished results). The subcutaneously implanted pucks transmitted through animal tissue successfully during these tests at distances of approximately 7 m, thus demonstrating the feasibility of using the telemetry device as an implant.
D. Full System "End-to-End" Calibration Showing Sensor Response to Glucose
Calibrations utilized a stirred 10-ml PBS solution at 37 C. The optocoupler bias voltage was adjusted to 1.420 VDC instead of 1.453 VDC. This was done to minimize the optocoupler voltage at sensor full scale glucose concentrations, for a lower op-amp battery current drain. Also, a higher resistance value at 0 mM provides a larger dynamic resistance range Fig. 5 shows a typical calibration sequence, starting with 0 mM glucose at time 13:26, at 600 k Glucose was added to reach concentrations of 5.66, 10.71, 15.25, and 19.35 mM, and showed decreasing resistance. The 1-min interval computer data was plotted without symbols, since they obscured the data. Note the noise-free plot. The well-defined steps reflect the sensor's short response time (30 s) and 1-min data interval. The nonlinear step distance is due to the optocoupler resistance versus the voltage nonlinearity characteristic only. The glucose sensor itself is quite linear, as will be shown in Fig. 7 . Fig. 6 is a plot of the average of three calibrations of one sensor. Small S.D. bars attest to the repeatability. The resistance range was from 520 k to 30 k This delta of 490 k from 0 mM to 19.35 mM, provides ample resolution, covering a good portion of the puck range. The curve in Fig. 6 reflects the optocoupler nonlinearity exclusively (see Fig. 4 ), since the sensor had a linear behavior ( ) as shown in Fig. 7 .
2) Subminiature Potentiostat Recorded Computer Resistances versus Glucose Concentrations:
E. Implanted Unit Battery Lifetime
The telemetry puck CR2025 internal battery can last three months with a transmission interval of 5 s, or one year at 10 min. The potentiostat itself, uses low quiescent current devices requiring 87 to 91 A at 3.7 VDC over the sensor range. With a AA-battery capacity of 2200 mAh it would last 24 176 h (1007 days). An optocoupler significantly increases the total current, to 304 A at 1000 nA sensor current, for an AA-battery lifetime of only 301 days. Thus, the threemonth puck life could be one year at longer intervals, and the subminiature potentiostat with optocoupler could last 300 days or more at less than 1000 nA. We estimate a lifetime of a year for the implantable unit with a AA battery, and six months with a smaller -AA size 3.7 VDC battery rated at 1000 mAh capacity.
F. Implantable Configuration for Subminiature Potentiostat and Telemetry Unit
Packaging of the components is under way as shown in Fig. 8 . The potentiostat board and optocoupler will be placed in a 26-mm diameter by 9-mm high cylindrical plastic container. The optocoupler's LED will be connected to the poten-tiostat voltage output, and its resistance leads to the telemetry puck (also 26-mm diameter by 9 mm high). Pins and sockets will be used to connect the sensor and proposed -AA battery power source.
Parylene can be used as a biocompatible sealant to insure a waterproof (body fluid proof) enclosure. Parylene is a xylylene polymer now used in the biomedical field, and is a conformal coating applied by vapor deposition [16] , [17] at room temperature (Parylene C preferred) in coating thicknesses of approximately 25 microns. Other possible medical use conformal coatings [16] , [17] include Silastic 382 RTV, F300 Saran, F310 Saran, Kel-F800 resins, or Stycast 1267 epoxy, Polyvinylidine Chloride (Saran 310), Polydimethyl Siloxane (Silicone) (Sylgard 184), Polyurethane (Elastomeric Adhesive A-386-96).
IV. CONCLUSIONS
This paper describes an easily implemented, subminiature potentiostat/telemetry unit for implantable glucose sensors utilizing a modified commercially available telemetry device. Remote monitoring of the glucose levels is easily done utilizing a small computer and telemetry receiver. With an external size "AA" battery, the implant package overall envelope will be 18 mm high, 26 mm wide, and 40 mm long. Individual component testing showed very stable performance. Breadboard and subminiature unit system testing showed the same excellent stability and accuracy, and correlated very well to standard potentiostat calibrations. We saw no data drop-out problems during orientation testing. Thus far, our testing has been done in vitro without encapsulation of the potentiostat assembly. However, the encapsulated telemetry puck has been successfully implanted by the Army in rhesus monkeys. Our tests verified that the assembled subminiature unit is able to monitor glucose concentrations in vitro very successfully. Our near term goal is encapsulation and in vivo testing of the implantable unit.
